Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
Abhik Kumar Ray, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Satyaranjan Biswal, Uddipan Bhattacharya, Malay Kumar Rana
Topics & Concepts
NelfinavirPharmacologyProteaseDocking (animal)AutoDockIndinavirChemistryStereochemistryVirologyEnzymeBiologyMedicineBiochemistryViral loadVirusVeterinary medicineAntiretroviral therapyGeneIn silicoComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchSynthesis and biological activity